JERUSALEM, May 09, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key ...

PMV Pharma ended the first quarter with $165.8 million in cash, cash equivalents, and marketable securities, compared to $183.3 million as of December 31, 2024. Net cash used in operations was $18.3 ...

Structured data and information systems are increasingly utilized to improve the efficiency and efficacy of financial investigations.

Highlights Total revenue of $1.54 billion, up 14% year over yearProduct revenue of $459 million, up 12% year over yearBillings of $1.60 billion, up 14% year over year1Unified SASE ARR2 up 26% and ...